Lead Product(s) : Nelfinavir Mesylate
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : National Cancer Institute | The Emmes Company, LLC | University of Arkansas | University of California, Los Angeles | AIDS and Cancer Specimen Resource | Montefiore Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 13, 2017
Lead Product(s) : Nelfinavir Mesylate
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : National Cancer Institute | The Emmes Company, LLC | University of Arkansas | University of California, Los Angeles | AIDS and Cancer Specimen Resource | Montefiore Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
